Vuja De Sciences

About:

Vuja De Sciences develops cancer metastasis treatments that prevent cancer progression and recurrence.

Website: https://vujade-life.com

Description:

Vuja De Sciences develops cancer metastasis treatments that prevent cancer progression and recurrence. They utilize leading laboratory technologies for metastatic preclinical endpoints in combination with Comparative Oncology to de-risk and inform product development and maximize the likelihood of successful human oncology clinical trials. It approaches used for cancer maintenance therapy and adjuvant therapy target the same mechanisms applied to either primary tumors or macro-metastatic tumors.

Total Funding Amount:

$2.84M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hoboken, New Jersey, United States

Founded Date:

2017-01-01

Contact Email:

rl(AT)vujade-life.com

Founders:

David Warshawsky, Raphael Nir, Rick Lampe, Robert E. Hurst

Number of Employees:

1-10

Last Funding Date:

2024-05-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai